# Preventicus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/preventicus

- Industry: Healthcare IT
- Headquarters: Bensheim, Germany
- Website: www.preventis-online.de
- Total disclosed funding: $1.3M
- Latest round: Seed (Aug 3, 2014)
- Investors on record: 2

## About

Preventicus GmbH is a German company specializing in innovative point-of-care diagnostics, focusing on user-friendly solutions for monitoring health conditions in gastroenterology, oncology, and infectious diseases.Founded in 2014 in Bensheim, Germany, Preventicus GmbH develops advanced diagnostic solutions. The company is led by Thomas Huebner, who has a background in healthcare innovation. Preventicus has secured funding through 2 deals, with the latest being a Seed round in which they raised EUR 1.000 mn from High-Tech Gruenderfonds and D11Z.Ventures, bringing their total amount raised to EUR 1.000 mn and their current valuation to EUR 2.553 mn.Preventis GmbH specializes in point-of-care diagnostics, offering advanced products for gastroenterology, infectious diseases, reproductive medicine, and oncology. Their core technology, QuantOn®, facilitates the quantitative evaluation of lateral flow rapid tests via an app that scans and measures results. The offerings include tests for vitamin D levels, colon cancer screenings, and therapy monitoring for inflammatory bowel diseases, designed for both self-testing and professional healthcare use across global markets, particularly in Europe and North America.In the most recent year, 2023, Preventis GmbH reported revenue of EUR 2,190,767. The company's revenue model includes direct sales to healthcare facilities and consumers, utilizing app-based platforms like the SmarTest FIT® for colorectal cancer screening, which provides results through smartphones, thus improving diagnostic efficiency.Looking ahead, Preventicus GmbH aims to expand its product portfolio with new diagnostic tools designed for enhanced user experience, focusing on user feedback for development. The company plans to enter new markets, specifically targeting increased presence in North America and Asia by 2025. Recent funding from the Seed round will support these initiatives, allowing for the development of upcoming products and the expansion of their market reach.

## Funding rounds

- Seed, Aug 3, 2014, $1.3M — High-Tech Gruenderfonds, D11Z.Ventures

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- D11Z.Ventures (https://capitalatlas.ai/funds/d11z-ventures) — Seed